GROUP ONE TRADING LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is and the CUSIP is 800677906. A total of 3 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$14,547
-77.7%
40,600
-58.3%
0.00%
Q1 2024$65,277
+78.1%
97,400
+59.4%
0.00%
Q3 2023$36,648
+352.7%
61,100
+1228.3%
0.00%
Q1 2023$8,096
-41.4%
4,600
+4.5%
0.00%
Q4 2022$13,816
-82.9%
4,400
-73.3%
0.00%
Q3 2022$81,000
-45.6%
16,500
-54.0%
0.00%
Q2 2022$149,000
-47.0%
35,900
-25.8%
0.00%
Q1 2022$281,000
-81.0%
48,400
-75.4%
0.00%
-100.0%
Q4 2021$1,478,000
+19.3%
197,000
+43.3%
0.00%0.0%
Q3 2021$1,239,000
-64.3%
137,500
-52.6%
0.00%
-75.0%
Q2 2021$3,469,000
+29.7%
289,800
+35.8%
0.00%0.0%
Q1 2021$2,674,000
-14.8%
213,400
+6.2%
0.00%
-20.0%
Q4 2020$3,137,000
+85.2%
201,000
+12.1%
0.01%0.0%
Q3 2020$1,694,000
-43.5%
179,300
-46.4%
0.01%
-64.3%
Q2 2020$2,999,000
+189.5%
334,700
+105.7%
0.01%
+75.0%
Q1 2020$1,036,000
-72.7%
162,700
-64.2%
0.01%
-69.2%
Q4 2019$3,800,000
+51.3%
454,000
+63.5%
0.03%
+30.0%
Q3 2019$2,512,000
-32.7%
277,600
-19.9%
0.02%
-41.2%
Q2 2019$3,733,000
+46.2%
346,600
+29.5%
0.03%
+21.4%
Q1 2019$2,554,000
-34.4%
267,700
-21.1%
0.03%
-17.6%
Q4 2018$3,893,000
-6.5%
339,100
+38.0%
0.03%
+3.0%
Q3 2018$4,165,000
+42.9%
245,700
+19.7%
0.03%
+32.0%
Q2 2018$2,915,000
+121.7%
205,300
+196.7%
0.02%
+92.3%
Q1 2018$1,315,000
-27.9%
69,200
-37.8%
0.01%0.0%
Q4 2017$1,824,000
+2.2%
111,200
-6.5%
0.01%
-18.8%
Q3 2017$1,784,000
+13.0%
118,900
-33.7%
0.02%0.0%
Q2 2017$1,579,000
+299.7%
179,400
+136.4%
0.02%
+220.0%
Q1 2017$395,000
+74.8%
75,900
+2.6%
0.01%
+150.0%
Q4 2016$226,000
-64.7%
74,000
-46.5%
0.00%
-71.4%
Q3 2016$640,000
-28.7%
138,200
-10.8%
0.01%
-36.4%
Q2 2016$897,000
+30.4%
154,900
+36.1%
0.01%
+10.0%
Q1 2016$688,000
-60.7%
113,800
-40.7%
0.01%
-52.4%
Q4 2015$1,752,000
+11.5%
191,900
-31.1%
0.02%
-4.5%
Q3 2015$1,571,000
-42.7%
278,600
+12.7%
0.02%
-42.1%
Q2 2015$2,740,000
-8.0%
247,100
+30.1%
0.04%
-19.1%
Q1 2015$2,979,000
-23.3%
190,000
-25.6%
0.05%
-20.3%
Q4 2014$3,883,000
+79.5%
255,300
+27.3%
0.06%
+78.8%
Q3 2014$2,163,000
-13.1%
200,600
+23.1%
0.03%
-13.2%
Q2 2014$2,489,000
-63.7%
163,000
-57.0%
0.04%
-67.0%
Q1 2014$6,851,000
+414.0%
378,900
+294.7%
0.12%
+475.0%
Q4 2013$1,333,000
-11.4%
96,000
-33.1%
0.02%
-31.0%
Q3 2013$1,505,000
+269.8%
143,600
+175.6%
0.03%
+190.0%
Q2 2013$407,00052,1000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING LLC 97,400$65,2770.00%
SIMPLEX TRADING, LLC 9,900$60.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SANGAMO THERAPEUTICS INC shareholders